Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B

Cited by (743)

Items 601–700 of 743

1. Sulfasalazine exposure during pregnancy and lactation: reproductive outcomes in male rat offspring
   Simone Forcato, Ana Aquino, Lorena Ireno Borges, Maria Luiza Francisconi Lubanco Thomé, Júlia Oliveira Bilibio, Hannah Hamada Mendonça Lens, Rafaela Pires Erthal, Flávia Alessandra Guarnier, Glaura Scantamburlo Alves Fernandes, Daniela Cristina Ceccatto Gerardin · 2023 · Reproduction Fertility and Development
2. Co-drugs of aminosalicylates and nutraceutical amino sugar for ulcerative colitis
   Suneela Sunil Dhaneshwar, M. Sharma, Gaurav Vadnerkar · 2011 · Journal of Drug Delivery Science and Technology
3. 5-Aminosalicylic Acid Inhibits AcuteClostridium difficileToxin A-Induced Colitis in Rats
   Steven R. Vigna · 2014 · International Journal of Inflammation
4. A genome‐wide expression profile and system‐level integration of nuclear factor kappa B regulated genes reveals fundamental metabolic adaptations during cell growth and survival
   Valentine B. Andela, Edward M. Schwarz, Regis J. O’Keefe, Edward J. Puzas, Joseph D. Rosenblatt, Randy N. Rosier · 2005 · FEBS Letters
5. NF-κB: Critical Regulator of Inflammation and the Immune Response
   Andrea Lasar, Ralf B. Marienfeld, Thomas Wirth, Bernd Baumann · 2004 · Handbook of experimental pharmacology
6. Novel molecular strategies for preeclampsia management: a pathophysiological and therapeutic perspective
   Yunxia Lou, Yan Chen, Lanying Chen, Tianshuo Yang, Leilei He · 2025 · Hypertension in Pregnancy
7. Chapter 10 Gastrointestinal Manifestations of Rheumatoid Arthritis
   John M. Cafardi, Herbert Rakatansky, Graciela S. Alarcón · 2008 · Technical report
8. A Review of Ulcerative Colitis
   Nikhil A. Zanke, Tushar Dhekane, Ananta B. Ghonge, Ashwini A Zanke, Akshay. M. Akotakar · 2022 · International Journal of Technology
9. Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy
   Bharat Kumar Reddy Sanapalli, Ashwini S. Deshpande, Vidyasrilekha Sanapalli, Dilep Kumar Sigalapalli · 2024 · Diseases
10. Sulfasalazine induces apoptosis of HBx-expressing cells in an NF-κB-independent manner
    Young-Man Lee, Moonkyung Kang, Jung-Me Hwang, Su-Kyung Lee, Hyeseong Cho, Yeon-Soo Kim · 2009 · Virus Genes
11. Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications
    Ronni Wolf, Hagit Matz, Edith Orion, Binnur Tüzün, Yalçın Tüzün · 2002 · Clinics in Dermatology
12. Activation of NFκB in inflammatory bowel disease
    Roland Michael Schmid, G. Adler, Susanne Liptay · 1998 · Gut
13. Desirable and Adverse Effects of Antiinflammatory Agents on the Heart
    Massimo Imazio, Silvia Maestroni, A. Valenti, Véronique Laure Ramoni, Antonio Luca Brucato · 2017 · Elsevier eBooks
14. The inflammatory cytokine TNF contributes with RAC3-induced malignant transformation
    Mileni Soares Machado, Francisco Rosa, María Cecilia Lira, Alejandro Jorge Urtreger, María Fernanda Rubio, Mónica A. Costas · 2018 · EXCLI journal
15. Mesalazine Suppresses Proinflammatory Cytokines in Patients with Acute Anterior Uveitis Independently of HLA-B27
    Nikola Smatlik, Nourhan Mortada, Martin Röcken, Amir Sadegh Yazdi, Manfred Zierhut · 2021 · Ocular Immunology and Inflammation
16. NF-κB as a Therapeutic Target for Cardiovascular Disease
    Keiichi Hishikawa, Toshio Nakaki · 2002 · Heart Drug
17. Current Advances in Rheumatoid Arthritis Therapy
    D Isease · 2000
18. Identification of Plant-Based Bio-Actives in the Treatment of Ulcerative Colitis Using Virtual Screening and In Vivo Approaches
    Manjunath Dammalli, Bhavya Somalapura Gangadharappa, Vivek Chandramohan, Veeresh Prabhakar Veerapur, Thippeswamy Boreddy Shivanandappa, Bidarekere Eshwarappa Rangaswamy · 2024 · Proceedings of the National Academy of Sciences India Section B Biological Sciences
19. In silico identifying MET/FN1/TGFBI as molecular targets in drug-resistant head and neck cancer and preclinical repurposing sulfasalazine for enhanced therapeutic efficacy
    Ntlotlang Mokgautsi, Alexander T.H. Wu, Sheng‐Yao Cheng, Jih‐Chin Lee, Thomashire Anita George, Jia-Hong Chen · 2023 · Arabian Journal of Chemistry
20. The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis
    Huanhuan Chen, Huimin Wang, XiaoJing Xu, Yanan Hu, Jing Su, Dongdong Li, Zimu Li, Shixiang Feng, Jinming Liu, Huanxiang Zhang et al. · 2024 · International Immunopharmacology
21. Tulipalin A suppressed the pro-inflammatory polarization of M1 macrophage and mitigated the acute lung injury in mice via interference DNA binding activity of NF-κB
    Ke‐Gang Linghu, Yue-Ting Tuo, Wen-Qing Cui, Tai-Qin Li, Da-Song Wang, Ya-Ya Zhang, Jian Zhang, Tian Zhang, Yu-E Wang, Hua Yu et al. · 2024 · European Journal of Pharmacology
22. Recalcitrant urticaria controlled with a combination of mycophenolate mofetil and sulfasalazine
    Alyssa Gwen Ashbaugh, Jenny E. Murase · 2021 · International Journal of Women’s Dermatology
23. Pharmacology in the musculoskeletal system
    Anwen S. Williams, Rhian Goodfellow · 2013 · Nurse Prescribing
24. Supercritical fluid extract from maca alleviates colitis induced by dextran sulfate sodium in mice
    Jae‐Young Cho, Eun Hye Choi, Jung Il Kang, Changsun Choi, Hyang Sook Chun · 2013 · Food Science and Biotechnology
25. Conventional Medical Management of Crohn’s Disease: Sulfasalazine
    Miquel A. Gassull, Eduard Cabré · 2011 · Springer eBooks
26. Review Article Nuclear factor-kappaB in inflammatory bowel disease and colorectal cancer
    Sunjida Ahmed, Md. Zahidunnabi Dewan, Ruliang Xu · 2014
27. New Vistas in Anti-Inflammatory Therapy
    Nigel Wardle · 2001 · The Nephron journals/Nephron journals
28. Cellular signaling to NF-кB: Role in inflammation and therapeutic promise
    Marie Chabot‐Fletcher · 2000 · Birkhäuser Basel eBooks
29. Sulfasalazine disrupts the interaction between TNFα and TNFR1 thus inhibiting NF-kB signaling activation to promote bone fracture healing
    Jingwei Liu, Cheng Qiu, Xiaoxiong Wang, Ziqian Xiang, Junyuan Sun, Mingzheng Chang, Qingliang Ma, Yan Zhuang, Yunpeng Zhao, Qiang Yang et al. · 2025 · Journal of Pharmacological Sciences
30. Therapeutic potential of sulfasalazine for sarcopenia: Insights from mouse models and clinical data
    Meehee Park, Seungju Cho, Seonggyu Choi, Hwa‐Young Lee, Jandee Lee, Youngsuk Jo, Jisoo Park, Jongsun Park · 2025 · Experimental Gerontology
31. Autoimmune Pulmonary Alveolar Proteinosis Triggered by Salazosulfapyridine in a Patient With Rheumatoid Arthritis: A Case Report
    Tomoyuki Ikeuchi, Mitsuhiro Yamamoto, Hirokazu Touge, Naoto Burioka, Akira Yamasaki · 2025 · Cureus
32. NF-κB signaling drives rapid skeletal muscle atrophy in patients with breast cancer: the cost of fighting cancer with chemotherapy
    Joris Mallard, L. Debrut, Elyse Hucteau, Laura Somme, Hervé Bischoff, Fabien Moinard‐Butot, Pierre Coliat, Abdelmalek Bendjama, Léo Weltzer, Alexandre Sharifi Tafreshi et al. · 2026 · American Journal of Physiology-Cell Physiology
33. A hyaluronic acid-based microneedle platform for enhanced ferroptosis-induced tumor therapy and antibacterial applications
    Shijie Shangguan, Yangping Zhong, Zhe Huang, Yaxin Ma, Yan Chen, Xiaoshi Li, Sijie Shao, Panpan Xue, Xuemei Zeng, Shuangqian Yan · 2026 · Nano TransMed
34. El factor de transcripción nuclear kappa en las enfermedades humanas
    Ricardo Orlando Escarcega · 2010 · Redalyc (Universidad Autónoma del Estado de México)
35. Carcinogenesis in Ulcerative Colitis
    Adam Humphries, Noor Jawad, Ana Ignjatovic, James M. East, Simon John Leedham · 2012 · InTech eBooks
36. YULDA-HANSO-TANG ATTENUATES THE ENDOTOXIN-INDUCED INFLAMMATORY CYTOKINE PRODUCTION IN PERIPHERAL BLOOD MONONUCLEAR CELLS
    Hyun‐Ja Jeong, Sujin Kim, Hyung‐Min Kim, Jae‐Young Um, Phil‐Dong Moon, Sug-Min Jun, Seung‐Heon Hong · 2007 · International Journal of Neuroscience
37. Agents Which Inhibit NF‐κB Signaling Block Spontaneous Contractile Activity and Negatively Influence Survival of Developing Myotubes
    C. George Carlson, Lauren Stein, Elizabeth Dole, Ross M. Potter, David S. Bayless · 2015 · Journal of Cellular Physiology
38. Inflammatory Bowel Disease: A Genomic Picture Predicts a Changing Response From the Laboratory-Part II
    Eric B. Staros · 2004 · Laboratory Medicine
39. Inflammatory Bowel Disease Part I: Ulcerative Colitis - Pathophysiology and Conventional and Alternative Treatment Options Kathleen A. Head, ND and
    Julie S Jurenka · 2003
40. Experimental Immunosuppressive Agents
    J Klupp, Randall Ellis Morris · 2001 · Springer eBooks
41. Role of Nuclear Factor-κB Pathway in Gastrointestinal Inflammation and Cancer
    Muthu Kumaraswamy Shanmugam, Nadine E. G. Upton, Gautam Sethi, W.S. Fred Wong · 2012 · WORLD SCIENTIFIC eBooks
42. Chapter 80 – Treatment of Autoimmune Disease: Established Therapies
    Bevra Hannahs Hahn, Jennifer K. King · 2014
43. Treatment of Autoimmune Disease
    Bevra Hannahs Hahn, Jennifer K. King · 2013 · Elsevier eBooks
44. Alleviation of Intestinal Inflammation by Oral Supplementation of Unripe Apple Ethanolic Extract in Mice
    Ha Na Jang, Ui‐Jin Bae, Mi Jang, Sung Hyen Lee, Gi-Chang Kim · 2023 · Journal of the Korean Society of Food Science and Nutrition
45. Case report: Rare neurological symptoms of sulfasalazine‐induced hypersensitivity syndrome
    Yiqi Shen, Sijie Li, Mengting Qian, Xiaoru Xia · 2024 · International Journal of Rheumatic Diseases
46. Protective Effect of Perilla Seed Meal and Perilla Seed Extract against Dextran Sulfate Sodium-Induced Ulcerative Colitis through Suppressing Inflammatory Cytokines in Mice
    Natticha Sumneang, Komsak Pintha, Sarawut Kongkarnka, Maitree Suttajit, Napapan Kangwan · 2024 · Molecules
47. NFκB Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases
    Hironori Nakagami, Mariana Kiomy Osako, Naruya Tomita, Ryuichi Morishita · 2008 · Springer eBooks
48. Anti-inflammatory effect of Equisetum hyemale via suppression of nuclear factor-κB activation in human mast cells
    So-Ra Jeon, Ho-Jeong Na, Hoon Jeon · 2009 · Oriental Pharmacy and Experimental Medicine
49. Expression of epithelial growth factor receptor, tumor necrosis factor-α and nuclear factor κB in inflammatory bowel diseases
    Łukasz Durko, Olga Stasikowska‐Kanicka, Małgorzata Wągrowska‐Danilewicz, Marian Danilewicz, Ewa I. Malecka-Panas · 2013 · Gastroenterology Review
50. Conventional disease-modifying drugs
    David Lloyd Scott · 2020
51. Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy
    Laurence John Egan, William J. Sandborn · 2007 · Springer eBooks
52. Targeting DMARD resistance in Rheumatoid Arthritis
    Joost W van der Heijden · 2008 · Pure Amsterdam UMC
53. Bases farmacológicas y tratamiento de la inflamación
    Domingo Espinós Pérez, Antonio López Buenadicha, Elpidio Calvo Manuel · 2004 · Monografías de la Real Academia Nacional de Farmacia
54. Tools to Interfere with NF-κB Activation
    Yumi Yamamoto, Udit N. Verma, Richard B. Gaynor · 2003 · Springer eBooks
55. Novel therapies based on enhancement of gut innate immunity in inflammatory bowel disease
    René Fiasse, Olivier Dewit · 2007 · Expert Opinion on Therapeutic Patents
56. Mesalamine for prophylaxis of small bowel Crohn’s disease recurrence
    William M. Bauer, Aaron Brzezinski, Bret A. Lashner · 1999 · Current Gastroenterology Reports
57. Regulation of male germ cell apoptosis : Roles of sex steroids and the cellular death receptors Fas and TNFR1
    Virve Pentikäinen · 2002 · Työväentutkimus Vuosikirja
58. SLC19A1 is a cyclic dinucleotide transporter
    Rutger David Luteijn, Shivam A. Zaver, Benjamin G. Gowen, Stacia K. Wyman, Nick E. Garelis, Liberty Onia, Sarah M. McWhirter, George E. Katibah, Jacob E. Corn, Joshua John Woodward et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
59. Molekulare Grundlagen der Behandlung rheumatischer Erkrankungen
    Hanns‐Martin Lorenz · 2003 · Springer eBooks
60. Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy
    Laurence John Egan, William J. Sandborn · 2003 · Springer eBooks
61. Exploration of the relationship between hypoxia and measures of clinical status and inflammation in children with cystic fibrosis
    Don S. Urquhart · 2010 · UCL Discovery (University College London)
62. The nuclear factor kappa b (NFkb) plays a critical role in the development of antiestrogen resistance
    Ruchi Nehra · 2009 · DigitalGeorgetown (Georgetown University Library)
63. Regulación de la expresión génica de leptina por estradiol en células placentarias
    Yésica P. Gambino · 2013 · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
64. Charakterisierung der durch hydrophobe Gallensäuren induzierten Leberzellschädigung und deren Modulation durch Phosphatidylinositol-3-Kinasen und Sulfasalazin
    Kris Bauchmüller · 2005
65. Estudio de los mecanismos que regulan la expresión y función del ligando de muerte TRAIL en células T normales y leucémicas
    Jorge Carlos Morales Camino · 2011
66. Protein Metabolism in Surgery
    Per-Olof J. Hasselgren · 2001 · Springer eBooks
67. Modulation of the IκB Kinase/Nuclear Factor-κB Pathway by Gene Therapy
    Paul Peter Tak, Gary S. Firestein · 2002 · Humana Press eBooks
68. Nachweis und Quantifizierung Defensin-positiver Zellen im subepithelialen Ileum von Morbus Crohn-Patienten unter immunsuppressiver Therapie
    Maja Vorwerk · 2010 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
69. Konventionelle Basistherapie der rheumatoiden Arthritis
    Gernot Keyßer · 2012 · Zeitschrift für Rheumatologie
70. Screening young people for gastric cancer Reply
    Daya Karat, John Wayman, Nick Hayes, S A Raimes, S M Griffin, Roland Valori, N A Shepherd · 1998 · Gut
71. Epithelial barrier and dendritic cell function in the intestinal mucosa
    Marleen I. Verstege · 2010 · UvA-DARE (University of Amsterdam)
72. Immunmodulatorische Therapie der rheumatoiden Arthritis: Therapiestrategien im Wandel der Zeit
    Burkhard Hinz · 2005 · Pharmazie in unserer Zeit
73. Nuclear Factors Linking Cancer and Inflammation
    Kunzang Chosdol, Mohita Bhagat, Bhawana Dikshit, Evanka Madan, Parthaprasad Chattopadhyay, Subrata Sinha · 2013 · Cancer drug discovery and develogment/Cancer drug discovery and development
74. In‐Depth Look: Anti‐TNF‐α Therapies
    Satadal Chatterjee, Shobhan Gaddameedhi · 2011 · Wiley eBooks
75. Glucocorticoid Sensitivity in Rheumatoid Arthritis
    R. A. M. Quax · 2013 · EUR Research Repository (Erasmus University Rotterdam)
76. Effects of Sulfasalazine Treatment in Juvenile Idiopathic Arthritis: Clinical and Radiological Observations
    Marion A. J. van Rossum · 2007 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
77. Novel biosensors for preclinical brain tumor analysis
    Johanna M. Niers · 2011 · Pure Amsterdam UMC
78. Inducible Nitric Oxide Synthase As a Target of Anti-inflammatory Treatment Modalities
    Mari Hämäläinen · 2009 · Tampere University Institutional Repository (Tampere University)
79. Application of recombinant DNA technology to the identification of novel therapeutic targets in inflammatory bowel disease
    Gary Wild, Jahanara Hasan, Mark J. Ropeleski, Kevin A. Waschke, Chantal Cossette, Line Dufresne, B. Q. H. Le, Alan B.R. Thomson · 2000 · Springer eBooks
80. Antenatal brain injury and prospects for neuroprotection
    Burcu Sağlam · 2017 · Figshare
81. NEW APPROACHES TO THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIA
    Martin H. Steinberg, Bernard G. Forget, Douglas R. Higgs, David John Weatherall · 2009 · Cambridge University Press eBooks
82. Current Medical Treatment for Inflammatory Bowel Disease
    Keiichi Mitsuyama · 2003 · Nihon Daicho Komonbyo Gakkai Zasshi
83. Konventionelle Basistherapie der rheumatoiden Arthritis Wirkungen in und außerhalb der Zelle
    Ulf Müller‐Ladner · 2012
84. Untersuchungen zur Compliance und Verträglichkeit der Sulfasalazin- Therapie bei rheumatoider Arthritis und seronegativen Spondylarthropathien
    Detlef Schlöndorff · 2002
85. STUDIO DEL MECCANISMO D'AZIONE DEL 17 β-ESTRADIOLO SULL'ATTIVAZIONE DI NF- κB
    Adriana C. Maggi, Elisabetta Vegeto · 2004
86. NF-κB in Human Cancers
    Elaine J. Schattner, Richard R. Furman, Alejandro Bernal · 2007 · Springer eBooks
87. NF-κB-dependent responses activated by bacterial–epithelial interactions
    Bobby J. Cherayil · 2006 · Cambridge University Press eBooks
88. Flavanols and NF-_B Activation
    Patricia I. Oteiza, César G. Fraga · 2008 · Oxidative stress and disease
89. Sulfasalazin rINN, USAN, Sulphasalazine BAN
    Herman Hans Waldvogel · 2001 · Springer eBooks
90. Universidade Estadual Paulista Instituto de Biociências Campus de Botucatu HSP70, Heparanase e HPRT participam da resposta inflamatória intestinal induzida por TNBS em ratos.
    Ana Carolina Elisa, Valencise Quaglio · 2011
91. Alternativen zur immunsuppressiven Therapie
    Michael Meurer · 1999 · Fortschritte der praktischen Dermatologie und Venerologie
92. Non‐Targeted Therapeutics for Inflammatory Bowel Diseases
    Gerhard Rogler · 2010 · Wiley eBooks
93. Chapter 80 – Treatment of Autoimmune Disease: Established Therapies
    Bevra Hannahs Hahn, Jennifer K. King · 2014 · Academic Press eBooks
94. Atividades in vitro e in vivo do fruto do guajiruzeiro (Chrysobalanus icaco L.) em biomarcadores de estresse oxidativo, danos ao DNA e inflamação e inflamação
    Vinícius Paula Venâncio · 2018
95. DYNAMICS OF THE GUT VIROME AND BACTERIAL MICROBIOME IN PEDIATRIC CROHN’S DISEASE PATIENTS
    Casey M. A. Jones · 2018 · DalSpace (Dalhousie University)
96. Molecular Mechanisms of Metabolic Reprogramming in Pancreatic Cancer
    Sonam Kumari · 2019
97. Activation of hepatic stellate cells under hypoxia and the inhibition of HSCs activation by TGF-b binding protein Decorin
    Yuefeng Shi · 2007
98. Adverse events in clinical studies in rheumatoid arthritis
    Mark Yates, James Benjamin Galloway · 2020
99. Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy
    Na Xie, Canhua Huang · 2021 · Springer eBooks
100. From association to function: elucidating the role of G Protein Signaling Modulator 3 and variants in its gene locus in rheumatoid arthritis
     Bryan Gall · 2016